|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | BCLC策略:预后预测和治疗推荐2022版更新显示文摘2018版BCLC预后和治疗推荐策略发布后,肝细胞癌(简称HCC)的研究又取得了重大进展。本次更新基于肝癌各领域的研究进展结果。重点关注影响策略的重要研究进展。虽然近年的研究结果成绩斐然,但将其引入为临床医生和研究者提供行动依据的循证模型指南来说证据效力依然不够确切。本文对该问题进行分析,阐述了为HCC患者制定个体化治疗临床决策所需的批判性思维和专业知识。 | Reig M Forner A Rimola J Ferrer-Fabrega J Burrel M Garcia-Criado A Kelley RK Galle PR Mazzaferro V Salem R Sangro B Singal AG Vogel A Fuster J Ayuso C Bruix J 刘永凡(摘译) 崔笑(摘译) 耿小平(审校) | 2022 | 肝胆外科杂志2022，30，5： | 80 |
| 2 | Management of nonalcoholic fatty liver disease:An evidence-based clinical practice review显示文摘AIM:To build a consensus among Chilean specialists on the appropriate management of patients with nonalcoholic fatty liver disease(NAFLD)in clinical practice.METHODS:NAFLD has now reached epidemic proportions worldwide.The optimal treatment for NAFLD has not been established due to a lack of evidence-based recommendations.An expert panel of members of the Chilean Gastroenterological Society and the Chilean Hepatology Association conducted a structured analysis of the current literature on NAFLD therapy.The quality of the evidence and the level of recommendations supporting each statement were assessed according to the recommendations of the United States Preventive Services Task Force.A modified three-round Delphi technique was used to reach a consensus among the experts.RESULTS:A group of thirteen experts was established.The survey included 17 open-ended questions that were distributed among the experts,who assessed the articles associated with each question.The levels of agreement achieved by the panel were 93.8%in the first round and 100%in the second and third rounds.The final recommendations support the indication of lifestyle changes,including diet and exercise,for all patients with NAFLD.Proven pharmacological therapies include only vitamin E and pioglitazone,which can be used in nondiabetic patients with biopsy-proven nonalcoholic steatohepatitis(the progressive form of NAFLD),although the long-term safety and efficacy of these therapies have not yet been established.CONCLUSION:Current NAFLD management is rapidly evolving,and new pathophysiology-based therapies are expected to be introduced in the near future.All NAFLD patients should be evaluated using a three-focused approach that considers the risks of liver disease,diabetes and cardiovascular events. | Juan P Arab Roberto Candia Rodrigo Zapata Cristián Mu?oz Juan P Arancibia Jaime Poniachik Alejandro Soza Francisco Fuster Javier Brahm Edgar Sanhueza Jorge Contreras M Carolina Cuellar Marco Arrese Arnoldo Riquelme | 2014 | World Journal of Gastroenterology2014，20，34： | 11 |
| 3 | High risk of thromboemboli early after bioprosthetic cardiac valve replacement显示文摘 | Heras M Chesebro JH Fuster V | 1995 | Am Coll Cardiol1995，25，： | 1 |
| 4 | Molecular imaging for the diagnosis of high-risk plaque显示文摘 | SIROL M FUSTER V TOUSSAINT JF | 2003 | Arch Mal Coeur Vaiss2003，96，12： | 1 |
| 5 | Optimization of millimeter-wave signal generation through FM-IM conversion in chirped fiber gratings 显示文摘 | Marti J Fuster J M Ramos F | 2000 | Microwave and Optical Technology Letters2000，27，6： | 1 |
| 6 | Frontal lobe and cognitive development 显示文摘 | Fuster J M | 2002 | J Neuroeytol2002，31，35： | 1 |
| 7 | Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses显示文摘 | Wang L Fuster M Sriramarao P | 2005 | Nat Immunol2005，6，9： | 1 |
| 8 | One-step reverse transcription polymerase chain reaction for semiquantitative analysis of mRNA expression显示文摘 | Fuster G Vicente R Coma M | 2002 | Methods Find Exp Clin Pharmaco12002，24，5： | 1 |
| 9 | Overcoming restenosis with sirolimus From alphabet soup to clinical reality 显示文摘 | Pooh M Badimon JJ Fuster V | 2002 | Lancet2002，359，9306： | 1 |
| 10 | Intention - to - treat analysis of surgical treatment for early hepatoeellular carcinoma:resati- on versus transplantation 显示文摘 | Llovet J M Fuster J Bruix J | 1993 | Hepatanogy1993，30，： | 1 |
| 11 | Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity显示文摘 | Samhol A Osende J Hathcock J Deqen M Nemerson Y Fuster V | 2003 | Circulation2003，107，7： | 1 |
| 12 | General Expressions for IM/DD Dispersive Analog Optical Links with External Modula- tion or Optical Up - Conversion in a Mach- Zehnder Electroopti- cal Modulator显示文摘 | CORRAL J L MARTI J FUSTER J M | 2001 | IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES2001，49，10： | 1 |
| 13 | ACC/AHA guidelines for the martagement of patients with ST-elevation myocardial infarction-executive summary:port of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of patients with Acute Myocardial Infarction) 显示文摘 | Antman EM Anbe DT Armstrong PW Bates ER Green LA Hand M Hochman JS Krumholz HM Kushner FG Lamas GA Mullany CJ Ornato JP pearle DL Sloan MA Smith SCJr Alpert JS Anderson JL Faxon DP Fuster V Gibbons RJ Gregoratos G Halperin JL Hiratzka LF Hunt SA Jacobs AK American College of Cardiology American Heart Association Task Force on Practice Guidelines | 2004 | Circulation2004，110，5： | 1 |
| 14 | Molecular imaging for the diagnosis of high-risk plaque 显示文摘 | Sirol M Fuster V Toussaint JF | 2003 | Arch Mal Coeur Vaiss2003，96，12： | 1 |
| 15 | Chronic endothelial dysfunction after oversized eoronary balloon angioplasty in pigs:a 12 - week follow - up of eoronary vaso reaetivity in vivo and in vitro显示文摘 | Fonseea F A Izar M C Fuster V | 2001 | At heroselerosis2001，154，1： | 1 |
| 16 | Thrombosis in cardiovascular disorders显示文摘 | Fuster V Verstraete M | 1992 | WB Saundrs1992，，： | 1 |
| 17 | Cardiac magnetic resonance imaging:a 'one-stop-shop' evaluation of myocardial dysfunction显示文摘 | Poon M Fuster V Fayad Z | 2002 | Curr Opin Cardiol2002，17，3： | 1 |
| 18 | Insights into the pathogenesis of acute ischemic syndromes 显示文摘 | Fuster V Badimon L Cohn M | 1988 | Circultion1988，77，6： | 1 |
| 19 | Osculat-ing hyperplanes and asymptotic direction of codimension2-submanifolds of Euclidean spaces显示文摘 | MochidaD K H Romero Fuster M C Ruas MAS | 1999 | Geon Dedicate1999，77，3： | 1 |
| 20 | Overcoming restenosis with sirolimus: from alphabet soup to clinical reality显示文摘 | Poon M Badimon J J Fuster V | 2002 | l ancet2002，259，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员